Skip to main content
JAMA Network logoLink to JAMA Network
. 2025 Apr 23;10(6):635. doi: 10.1001/jamacardio.2025.1212

Error in Figure 2

PMCID: PMC12019666  PMID: 40266587

The Original Investigation titled “Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial,”1 published online January 8, 2025, and in the March 2025 issue of JAMA Cardiology was corrected to remove the percentage symbol from the x-axis label, fix a duplicate x-axis tick mark, and correct the position of the noninferiority margin in Figure 2, panel A, and to add the meaning of the vertical dashed line in the Figure 2, panel A caption. This article was corrected online.

Reference

  • 1.Gustafsson F, Uriel N, Netuka I, et al. ; ARIES Investigators . Aspirin and hemocompatibility after LVAD implantation in patients with atherosclerotic vascular disease: a secondary analysis from the ARIES-HM3 randomized clinical trial. JAMA Cardiol. 2025;10(3):235-242. doi: 10.1001/jamacardio.2024.4849 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Cardiology are provided here courtesy of American Medical Association

RESOURCES